# Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis

> **NCT03580733** · PHASE3 · RECRUITING · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 448 (estimated)

## Conditions studied

- ICU Yeast Intra-abdominal Infection

## Interventions

- **DRUG:** caspofungin antifungal therapy
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03580733
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-01
- **Primary completion:** 2024-10-04
- **Final completion:** 2024-12-04
- **Target enrollment:** 448 (ESTIMATED)
- **Last updated:** 2024-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03580733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03580733, "Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03580733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*